Workflow
ptis Therapeutics (COEP)
icon
Search documents
ptis Therapeutics (COEP) - 2020 Q4 - Annual Report
2021-03-30 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39669 BULL HORN HOLDINGS CORP. (Exact name of registrant as specified in its charter) | --- | --- | |---------------------------------- ...
ptis Therapeutics (COEP) - 2020 Q3 - Quarterly Report
2020-12-10 01:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 British Virgin Islands 98-1465952 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Title of each class Trading Symbol(s) Name of each exchange on which registered Units, each consisting of one Ordinary Share and one Redeemable Warrant BHSEU The Nasdaq Stock Market LLC Ordinary Shares BHSE The Nasdaq Stock Market LLC Warrants, each whole warrant exercisable for one-half of one Ordinary S ...